HM013 5 mg Pill - red & white capsule/oblong, 19mm
Generic Name: fruquintinib
Pill with imprint HM013 5 mg is Red & White, Capsule/Oblong and has been identified as Fruzaqla 5 mg. It is supplied by Takeda Pharmaceutical Company Limited.
Fruzaqla is used in the treatment of Colorectal Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. Fruzaqla 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HM013 5 mg
Fruzaqla
- Generic Name
- fruquintinib
- Imprint
- HM013 5 mg
- Strength
- 5 mg
- Color
- Red & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 63020-0225
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Lonsurf
Lonsurf is an oral combination tablet that contains tipiracil and trifluridine which may be used to ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Krazati
Krazati (adagrasib) is a targeted therapy for non-small cell lung cancer (NSCLC) and colorectal ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
More about Fruzaqla (fruquintinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.